Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Short-Term Debt issuances (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Short-Term Debt issuances over the past 12 years, most recently at -$6.0 million for Q1 2025.

  • Quarterly results put Short-Term Debt issuances at -$6.0 million for Q1 2025, down 297.69% from a year ago — trailing twelve months through Feb 2025 was $129.3 million (up 120.81% YoY), and the annual figure for FY2024 was $149.6 million, up 375.63%.
  • Short-Term Debt issuances for Q1 2025 was -$6.0 million at Lifecore Biomedical, Inc. \De\, up from -$13.1 million in the prior quarter.
  • Over the last five years, Short-Term Debt issuances for LFCR hit a ceiling of $146.5 million in Q2 2024 and a floor of -$32.0 million in Q1 2023.
  • Median Short-Term Debt issuances over the past 5 years was $4.0 million (2022), compared with a mean of $17.4 million.
  • Biggest five-year swings in Short-Term Debt issuances: soared 449.01% in 2023 and later tumbled 492.45% in 2024.
  • Lifecore Biomedical, Inc. \De\'s Short-Term Debt issuances stood at $18.0 million in 2021, then crashed by 77.78% to $4.0 million in 2022, then plummeted by 155.3% to -$2.2 million in 2023, then tumbled by 492.45% to -$13.1 million in 2024, then skyrocketed by 54.22% to -$6.0 million in 2025.
  • The last three reported values for Short-Term Debt issuances were -$6.0 million (Q1 2025), -$13.1 million (Q4 2024), and $1.9 million (Q3 2024) per Business Quant data.